Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Larissa A Pikor
Affiliation
Ottawa Hospital Research Institute
ORCID
Career Start Year
2010
Papers
32
H Index
24
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36405739
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.
Front Immunol
2022
35393414
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.
Nat Commun
2022
29367345
Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.
Sci Transl Med
2018
29921327
Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference.
J Immunother Cancer
2018
29507679
Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes.
Oncotarget
2018
27096814
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
Epigenomics
2016
26583808
Macrophages, Inflammation, and Lung Cancer.
Am J Respir Crit Care Med
2016
27357447
Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma.
J Pathol
2016
26809501
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression.
Mol Oncol
2016
24596130
Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancer.
Head Neck
2015
28741515
Oncolytic Viruses: Exploiting Cancer's Deal with the Devil.
Trends Cancer
2015
25907283
Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer.
Int J Cancer
2015
26013764
Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology.
Sci Rep
2015
23318427
SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling.
Oncogene
2014
25594027
SOX15 and other SOX family members are important mediators of tumorigenesis in multiple cancer types.
Oncoscience
2014
25342220
Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology.
BMC Cancer
2014
25114896
Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancer.
Biomed Res Int
2014
24519926
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer.
Oncotarget
2014
23633034
The detection and implication of genome instability in cancer.
Cancer Metastasis Rev
2013
24138990
Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer.
Mol Cancer
2013
24170126
YEATS4 is a novel oncogene amplified in non-small cell lung cancer that regulates the p53 pathway.
Cancer Res
2013
23942079
Mutational analysis of Polycomb genes in solid tumours identifies PHC3 amplification as a possible cancer-driving genetic alteration.
Br J Cancer
2013
24011633
Genetic alterations defining NSCLC subtypes and their therapeutic implications.
Lung Cancer
2013
22427650
Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling pathway in mammary carcinoma.
J Biol Chem
2012
22852089
Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications.
Genet Res Int
2012
22629454
Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.
PLoS One
2012
22328562
Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.
Clin Cancer Res
2012
21490570
DNA extraction from paraffin embedded material for genetic and epigenetic analyses.
J Vis Exp
2011
21795997
Genetic disruption of KEAP1/CUL3 E3 ubiquitin ligase complex components is a key mechanism of NF-kappaB pathway activation in lung cancer.
J Thorac Oncol
2011
21541180
MicroRNA gene dosage alterations and drug response in lung cancer.
J Biomed Biotechnol
2011
20020444
Methylation analysis by DNA immunoprecipitation.
J Cell Physiol
2010
20682026
A sequence-based approach to identify reference genes for gene expression analysis.
BMC Med Genomics
2010
1 - 32 of 32
Column Actions
Search
Recommended Authors
Reanne Bowlby
Career Start Year
2015
Number of shared co-authors
1
Yari Ciani
University of Trento
Career Start Year
2012
Number of shared co-authors
0
Olga Bogatyrova
German Cancer Research Center
Career Start Year
2010
Number of shared co-authors
2
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year
2008
Number of shared co-authors
0
Salvatore Piscuoglio
University of Basel
Career Start Year
2008
Number of shared co-authors
1
Wei Zhang
Montefiore Medical Center
Career Start Year
2008
Number of shared co-authors
3
Yang Xie
Quantitative Biomedical Research Center
Career Start Year
2007
Number of shared co-authors
2
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year
2007
Number of shared co-authors
0
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
0
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
0
Matthew D Wilkerson
Uniformed Services University of the Health Sciences
Career Start Year
2004
Number of shared co-authors
0
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
2
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
1
Andrew V Kossenkov
The Wistar Institute
Career Start Year
2003
Number of shared co-authors
0
Michael Slifker
Fox Chase Cancer Center
Career Start Year
2002
Number of shared co-authors
0
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year
2001
Number of shared co-authors
1
Luciano G Martelotto
Monash University
Career Start Year
2000
Number of shared co-authors
3
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year
1999
Number of shared co-authors
0
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year
1999
Number of shared co-authors
2
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year
1999
Number of shared co-authors
2
Barbara A Weir
Janssen Research and Development LLC
Career Start Year
1997
Number of shared co-authors
5
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
4
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year
1996
Number of shared co-authors
1
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year
1993
Number of shared co-authors
1
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year
1993
Number of shared co-authors
8
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
0
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year
1987
Number of shared co-authors
2
Matthew Meyerson
Broad Institute
Career Start Year
1983
Number of shared co-authors
6
row(s) 1 - 30 of 30
Collaborators
Wan L Lam
British Columbia Cancer Research Institute
Co-authored papers
26
Raj Chari
The National Institutes of Health
Co-authored papers
6
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers
6
John C Bell
Ottawa Hospital Research Institute
Co-authored papers
5
Jean-Simon Diallo
Ottawa Hospital Research Institute, University of Ottawa
Co-authored papers
4
Carolina S Ilkow
Ottawa Hospital Research Institute
Co-authored papers
4
Yuzhuo Wang
University of British Columbia
Co-authored papers
3
Mathieu J F Crupi
Cancer Research Institute, Queen's University
Co-authored papers
3
Adrian Pelin
University of Ottawa
Co-authored papers
3
Igor Jurisica
Schroeder Arthritis Institute
Co-authored papers
3
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers
3
Varune R Ramnarine
University of British Columbia
Co-authored papers
2
Taha Azad
Ottawa Hospital Research Institute
Co-authored papers
2
Xiao-Peng He
Ottawa Hospital Research Institute
Co-authored papers
2
Zaid Taha
Ottawa Hospital Research Institute, University of Ottawa
Co-authored papers
2
Julia Petryk
Ottawa Hospital Research Institute
Co-authored papers
2
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Co-authored papers
2
Rebecca C Auer
The Ottawa Hospital Research Institute
Co-authored papers
2
Kim N Chi
University of British Columbia
Co-authored papers
2
Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Brian A Keller
The Ottawa Hospital/University of Ottawa
Co-authored papers
2
Akira Watahiki
Co-authored papers
2
Sarwat T Khan
Ottawa Hospital Research Institute
Co-authored papers
2
Michele Geoffrion
University of Ottawa Heart Institute
Co-authored papers
1
Martin E Gleave
University of British Columbia
Co-authored papers
1
Alan Melcher
The Institute of Cancer Research
Co-authored papers
1
Victoria A Jennings
Leeds Institute of Medical Research at St James's, University of Leeds
Co-authored papers
1
Hayley E McKay
Ottawa Hospital Research Institute
Co-authored papers
1
Katey J Rayner
University of Ottawa
Co-authored papers
1
Abera Surendran
Ottawa Hospital Research Institute, The Ottawa Hospital
Co-authored papers
1
1 - 30